We were the first lupus organization in the U.S. to support stromal cell research. In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate into cells of the chondrogenic lineage have led to a variety of experimental strategies to investigate ...

Stem cells grown in microgravity aboard the International Space Station (ISS) are showing potential to transform treatments ...

The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

Hope Biosciences' stem cell therapy led to improved scores on a quality-of-life test for MS patients in a small clinical trial.